Tirofiban usage and prognosis after myocardial infarction (Author`s Reply)

References (2)

1. Kaymaz C, Keleş N, Özdemir N, Tanboğa İH, Demircan HC, Can MM, et al. The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI. Anatol J Cardiol 2014 Dec 25. Epub of ahead of print
2. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358: 2205-17. [CrossRef] 3. Jeremias A, Vasu S, Gruberg L, Kastrati A, Stone GW, Brown DL. Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting. Catheter Cardiovasc Interv 2010; 75: 895-902. [CrossRef] 4. Mrdovic I, Savic L, Lasica R, Krljanac G, Asanin M, Brdar N, et al. Efficacy and safety of tirofiban-supported primary percutaneous coronary interven-tion in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register. Eur Heart J Acute Cardiovasc Care 2014; 3: 56-66. [CrossRef] 5. Zhu J, Zhang T, Xie Q, Zhang J. Effects of upstream administration of tirofi-ban before percutaneous coronary intervention on spontaneous reperfu-sion and clinical outcomes in acute ST-segment elevation myocardial infarction. Angiology 2015; 66: 70-8. [CrossRef]